Novel albendazole-chitosan nanoparticles for intestinal absorption enhancement and hepatic targeting improvement in rats.

To improve the treatment of helminthiasis, filariasis, and colorectal cancer, albendazole-associated chitosan nanoparticles (ABZ-CS-NPs) were prepared using the emulsion crosslinking volatile technique with contained sodium tripolyphosphate as the crosslinking agent and Poloxamer 188 as the auxiliary solvent. The structural characteristics of the NPs were determined using X-ray diffraction to analyze the interaction between CS and the drug. The NPs were then evaluated in terms of their physicochemical characteristics, drug release behavior, in vivo pharmacokinetic parameters, and biodistribution in animal studies. ABZ-loaded NPs with a uniformly spherical particle sizes (157.8 ± 2.82 nm) showed efficient drug loading, encapsulated efficiency, and high physical stability. The drug release from ABZ-CS-NPs was extended over several periods. Kinetic models were then fitted to determine the release mechanisms. ABZ and its metabolite albendazole sulfoxide (ABZSX) were analyzed in rats with mebendazole as the internal standard using reversed-phase high-performance liquid chromatography. Compared with the ABZ suspension groups, the relative bioavailability values of ABZ and ABZSX were 146.05 and 222.15%, respectively. In addition, the plasma concentration versus time curve is consistent with that of the two compartment models in the plasma concentration versus time curve. The results indicate that the ABZ-loaded NPs are promising novel ABZ candidates for passive diffusion in the treatment of hydatid cysts in the liver via oral administration.

Multidetector CT and MR imaging cardiac hydatidosis: case report and review of the literature.

Cardiac hydatid cysts are uncommon but potentially fatal. We present a case of isolated unilocular and multivesicular hydatid cysts in the heart, and provide a literature review of this rare condition. A 35-year-old man presented to our cardiology unit with acute chest pain. Computed tomography showed two cystic lesions in the heart. One unilocular cyst was located close to the left atrium and compressed the pulmonary artery. The other multivesicular cyst adhered to the left ventricle and displaced the left coronary arteries. T2-weighted magnetic resonance images revealed lesions in the pericardial cavity with bright signal intensity. Dot immunogold filtration assay was performed, and positive results for anti-EgCF antibody, anti-EgP antibody and anti-EgB antibody for cystic hydatidosis were found. Cardiac hydatidosis was diagnosed because of typical imaging findings and positive serology. The patient underwent surgical excision of the cysts. Postoperatively, symptoms of the patient resolved.